136 related articles for article (PubMed ID: 16425399)
1. MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells.
Hamada S; Satoh K; Kimura K; Kanno A; Masamune A; Shimosegawa T
World J Gastroenterol; 2005 Nov; 11(43):6867-70. PubMed ID: 16425399
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine inhibits proliferation and induces apoptosis in human pancreatic cancer PANC-1 cells.
Yong-Xian G; Xiao-Huan L; Fan Z; Guo-Fang T
J Cancer Res Ther; 2016 Oct; 12(Supplement):1-4. PubMed ID: 27721241
[TBL] [Abstract][Full Text] [Related]
3. Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine.
Chandler NM; Canete JJ; Callery MP
J Gastrointest Surg; 2004 Dec; 8(8):1072-8. PubMed ID: 15585396
[TBL] [Abstract][Full Text] [Related]
4. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
Wissniowski TT; Meister S; Hahn EG; Kalden JR; Voll R; Ocker M
Int J Oncol; 2012 May; 40(5):1581-9. PubMed ID: 22266985
[TBL] [Abstract][Full Text] [Related]
5. [A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM].
Yuan W; Sui CG; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):330-334. PubMed ID: 29860758
[No Abstract] [Full Text] [Related]
6. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.
Ou YQ; Zhu Wb; Li Y; Qiu PX; Huang YJ; Xie J; He SM; Zheng XK; Leng TD; Xu D; Yan GM
Acta Pharmacol Sin; 2010 Jan; 31(1):73-80. PubMed ID: 19966835
[TBL] [Abstract][Full Text] [Related]
7. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Clin Cancer Res; 2004 Apr; 10(7):2307-18. PubMed ID: 15073106
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells.
Christgen M; Schniewind B; Jueschke A; Ungefroren H; Kalthoff H
Cancer Lett; 2005 Sep; 227(2):193-200. PubMed ID: 16112422
[TBL] [Abstract][Full Text] [Related]
10. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
Jiang C; Yi XP; Shen H; Li YX
World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
[TBL] [Abstract][Full Text] [Related]
11. Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.
Chen J; Wu SY; Ou-Yang ZG; Zhen YS
Acta Pharmacol Sin; 2008 May; 29(5):614-9. PubMed ID: 18430374
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression.
Kurdow R; Schniewind B; Zoefelt S; Boenicke L; Boehle AS; Dohrmann P; Kalthoff H
Langenbecks Arch Surg; 2005 Jun; 390(3):243-8. PubMed ID: 15726400
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents.
Xu ZW; Friess H; Büchler MW; Solioz M
Cancer Chemother Pharmacol; 2002 Jun; 49(6):504-10. PubMed ID: 12107556
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract][Full Text] [Related]
16. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
[TBL] [Abstract][Full Text] [Related]
17. Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1).
Leja-Szpak A; Nawrot-Porąbka K; Góralska M; Jastrzębska M; Link-Lenczowski P; Bonior J; Pierzchalski P; Jaworek J
Pharmacol Rep; 2018 Dec; 70(6):1079-1088. PubMed ID: 30308458
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway.
Yao J; Qian C
Med Oncol; 2010 Sep; 27(3):1017-22. PubMed ID: 19816816
[TBL] [Abstract][Full Text] [Related]
19. Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells.
Kim N; Kang MJ; Lee SH; Son JH; Lee JE; Paik WH; Ryu JK; Kim YT
Anticancer Res; 2018 Jun; 38(6):3527-3533. PubMed ID: 29848706
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine].
Zhang J; Jiang H; Mao Z; Wang X; Fan X; Liu Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):335-40. PubMed ID: 25030587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
